OpenBilldrug price receipt

NADAC week of 2026-10-14

DEXTROAMPH-AMPHET ER 50 MG CAP

FDA nonproprietary name: dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate

For 30 capsules

Pharmacies pay

$243.22 filed

30 × $8.10719 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$284.70 estimated

$243.22 + $36.48 (15%) + $5.00 fee per fill = $284.70

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

DEXTROAMPH-AMPHET ER 50 MG CAP is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate” and “dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate”, as its NDCs’ listings variously write the nonproprietary name, under the trade name “Mixed Salts of a Single-Entity Amphetamine Product”.

FDA gives its dosage form as capsule, extended release and its route as oral.

Its labelers, the companies named on the label, are SpecGx LLC, Teva Pharmaceuticals, Inc. and Sun Pharmaceutical Industries, Inc.

FDA’s Established Pharmacologic Class for it is Central Nervous System Stimulant.

The NADAC file of 2026-10-14 prices it under 3 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $243.22 for 30 capsules (30 × $8.10719 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

All 3 NDCs

Other strengths, forms and brands

16 other products in the NADAC file share an FDA nonproprietary name with DEXTROAMPH-AMPHET ER 50 MG CAP.

ProductPharmacies pay per unitMedicare per unit
DEXTROAMP-AMPHET ER 5 MG CAP
generic · capsule / capsule, extended release
$0.49142 per EA filed
eff. 2026-09-23
We don’t know yet
DEXTROAMP-AMPHET ER 10 MG CAP
generic · capsule / capsule, extended release
$0.53946 per EA filed
eff. 2026-09-23
We don’t know yet
DEXTROAMP-AMPHET ER 15 MG CAP
generic · capsule / capsule, extended release
$0.55748 per EA filed
eff. 2026-09-23
We don’t know yet
DEXTROAMP-AMPHET ER 20 MG CAP
generic · capsule / capsule, extended release
$0.59656 per EA filed
eff. 2026-09-23
We don’t know yet
DEXTROAMP-AMPHET ER 25 MG CAP
generic · capsule / capsule, extended release
$0.48948 per EA filed
eff. 2026-09-23
We don’t know yet
DEXTROAMP-AMPHET ER 30 MG CAP
generic · capsule / capsule, extended release
$0.46559 per EA filed
eff. 2026-09-23
We don’t know yet
DEXTROAMP-AMPHETAM 7.5 MG TAB
generic · tablet
$0.27589 per EA filed
eff. 2026-09-23
We don’t know yet
DEXTROAMP-AMPHETAM 12.5 MG TAB
generic · tablet
$0.35923 per EA filed
eff. 2026-09-23
We don’t know yet
DEXTROAMP-AMPHETAMIN 10 MG TAB
generic · tablet
$0.23272 per EA filed
eff. 2026-09-23
We don’t know yet
DEXTROAMP-AMPHETAMIN 15 MG TAB
generic · tablet
$0.23513 per EA filed
eff. 2026-09-23
We don’t know yet
DEXTROAMP-AMPHETAMIN 20 MG TAB
generic · tablet
$0.29009 per EA filed
eff. 2026-09-23
We don’t know yet
DEXTROAMP-AMPHETAMIN 30 MG TAB
generic · tablet
$0.29556 per EA filed
eff. 2026-09-23
We don’t know yet
DEXTROAMP-AMPHETAMINE 5 MG TAB
generic · tablet
$0.26108 per EA filed
eff. 2026-09-23
We don’t know yet
DEXTROAMPH-AMPHET ER 12.5 MG CP
generic · capsule, extended release
$8.43593 per EA filed
eff. 2026-09-23
We don’t know yet
DEXTROAMPH-AMPHET ER 25 MG CAP
generic · capsule, extended release
$7.92393 per EA filed
eff. 2026-09-23
We don’t know yet
DEXTROAMPH-AMPHET ER 37.5 MG CP
generic · capsule, extended release
$8.65441 per EA filed
eff. 2026-09-23
We don’t know yet
DEXTROAMPH-AMPHET ER 50 MG CAP this page
generic · capsule, extended release
$8.10719 per EA filed
eff. 2026-09-23
We don’t know yet

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Compared with its class

The middle of its 3 NDCs’ NADAC prices is $8.10719 per EA filed.

Of the 203 other products in FDA’s Central Nervous System Stimulant class priced per EA, 75 have a higher middle NADAC price and 128 a lower one. The one in the middle is LISDEXAMFETAMINE 20 MG TB CHEW, at $4.33791 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.